Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure.

作者信息

Chilton Robert J

机构信息

Division of Cardiology, Department of Medicine, University of Texas Health Science Centre at San Antonio, San Antonio, Texas.

出版信息

Diabetes Obes Metab. 2021 May;23(5):1215-1218. doi: 10.1111/dom.14320. Epub 2021 Feb 26.

DOI:10.1111/dom.14320

PMID:33464709

Abstract

摘要

相似文献

Beyond the myocardium: Sodium-glucose co-transporter-2 inhibitors in heart failure.

Diabetes Obes Metab. 2021 May;23(5):1215-1218. doi: 10.1111/dom.14320. Epub 2021 Feb 26.

Sodium-glucose co-transporter 2 inhibitors and heart failure-the present and the future.钠-葡萄糖共转运蛋白 2 抑制剂与心力衰竭：现状与未来。

Heart Fail Rev. 2021 Jul;26(4):953-960. doi: 10.1007/s10741-020-09925-z.

The role of sodium glucose co-transporter inhibitors in heart failure prevention.钠葡萄糖协同转运蛋白抑制剂在预防心力衰竭中的作用。

J Diabetes Complications. 2021 Mar;35(3):107811. doi: 10.1016/j.jdiacomp.2020.107811. Epub 2020 Nov 26.

Treatment of heart failure: the dawn of the era of sodium-glucose co-transporter-2 inhibitors.心力衰竭的治疗：钠-葡萄糖协同转运蛋白2抑制剂时代的曙光。

Eur Heart J. 2020 Sep 21;41(36):3379-3383. doi: 10.1093/eurheartj/ehaa810.

Emerging Topics in Heart Failure: Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i) in HF.心力衰竭的新热点：心力衰竭中的钠-葡萄糖协同转运蛋白2抑制剂（SGLT2i）

Arq Bras Cardiol. 2021 Feb;116(2):355-358. doi: 10.36660/abc.20210031.

Sodium-glucose co-transporter-2 inhibitors and protection from cardiovascular death: Is it all about heart failure?钠-葡萄糖协同转运蛋白2抑制剂与预防心血管死亡：这一切都与心力衰竭有关吗？

Diabetes Obes Metab. 2021 Sep;23(9):2194-2196. doi: 10.1111/dom.14444. Epub 2021 Jun 9.

Sodium-glucose co-transporter-2 (SGLT-2) inhibitors and uric acid: More good news!钠-葡萄糖协同转运蛋白2（SGLT-2）抑制剂与尿酸：更多好消息！

J Diabetes Complications. 2023 Jul;37(7):108510. doi: 10.1016/j.jdiacomp.2023.108510. Epub 2023 May 21.

Pharmacology Focus: Clinical Evidence for the Use of Sodium-Glucose Co-transporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction.药理学聚焦：钠-葡萄糖协同转运蛋白2抑制剂用于射血分数保留的心力衰竭的临床证据

S D Med. 2022 Jul;75(7):328-329.

The role of sodium-glucose co-transporter (SGLT)-2 inhibitors in heart failure management and implications for the kidneys.钠-葡萄糖协同转运蛋白 2（SGLT）-2 抑制剂在心力衰竭管理中的作用及其对肾脏的影响。

Rev Cardiovasc Med. 2022 Mar 3;23(3):82. doi: 10.31083/j.rcm2303082.

[Serendipity of sodium-glucose co-transporter 2 inhibitors: a new paradigm in the management of heart failure with reduced ejection fraction].[钠-葡萄糖协同转运蛋白2抑制剂的意外收获：射血分数降低的心力衰竭管理新范式]

G Ital Cardiol (Rome). 2021 Apr;22(4):277-283. doi: 10.1714/3574.35573.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验